← Browse by Condition
Medical Condition

spinal stenosis

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for spinal stenosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — spinal stenosis Clinical Trials

How many clinical trials are currently recruiting for spinal stenosis?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for spinal stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for spinal stenosis?
spinal stenosis research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a spinal stenosis clinical trial?
Eligibility criteria for spinal stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
University of California, San Francisco 1 trial
Taipei Veterans General Hospital, Taiwan 1 trial
University of Colorado, Denver 1 trial
Jaseng Hospital of Korean Medicine 1 trial
Sklifosovsky Institute of Emergency Care 1 trial

Recruiting Clinical Trials

NCT06140927 Phase 3
Recruiting
Effect of Ketamine on Intraoperative Motor Evoked Potentials
Enrollment
20 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT03883022
Recruiting
Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery
Enrollment
400 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
View Trial →
NCT04601363
Recruiting
Personalized Spine Study Group (PSSG) Registry
Enrollment
1,000 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT02257723
Recruiting
The Effect of Integrated CAM Treatment in Hospitalized Patients
Enrollment
100,000 pts
Location
South Korea
Sponsor
Jaseng Hospital of Korean Medi...
View Trial →
NCT05273879
Recruiting
Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis
Enrollment
86 pts
Location
Russia
Sponsor
Sklifosovsky Institute of Emer...
View Trial →

Related Conditions

spinal fusion (3) spine fusion (1) spine tumor (1) spondylolisthesis (1) scoliosis adolescence (1) degenerative disc disease (1) kyphoscoliosis (1) pseudoarthrosis of spine (1) kyphoses scheuermann (1) low back pain (1) neck pain (1) knee pain (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology